Moreover, according to our analysis, the positive fluorescence of HEPH greatly increased both on the membranes and in the intracellular sites in G9a-knockdown or pharmacologically inhibited breast cancer cells (Fig. 3a). Here, EHMT2 is linked to breast carcinoma.